TERN vs USB
Terns Pharmaceuticals Inc (TERN) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
TERN currently screens at market cap $6.12B. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the TERN and USB stock pages for the full models.
Not investment advice.